Arcadia Biosciences, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 02/14/2023 | 537,494 | $145,661 | -66.61% | 89.67% |
| VANGUARD GROUP INC | 02/10/2023 | 307,300 | $83,278 | -59.04% | 51.27% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2023 | 282,419 | $76,536 | 85.06% | 47.12% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2023 | 185,438 | $50,000 | 444.33% | 30.94% |
| CITADEL ADVISORS LLC | 02/14/2023 | 181,437 | $49,169 | 100.00% | 30.27% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2023 | 177,475 | $48,000 | -0.28% | 29.61% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2023 | 144,500 | $39,000 | 8.24% | 24.11% |
| STATE STREET CORP | 05/15/2023 | 101,800 | $27,588 | 0.00% | 16.98% |
| HRT FINANCIAL LP | 02/10/2023 | 83,183 | $22,000 | 100.00% | 13.88% |
| HIGHTOWER ADVISORS, LLC | 02/09/2023 | 63,883 | $16,000 | 49.48% | 10.66% |
| JANE STREET GROUP, LLC | 02/15/2023 | 54,573 | $14,789 | 150.25% | 9.10% |
| ERGOTELES LLC | 02/14/2023 | 46,534 | $12,611 | 100.00% | 7.76% |
| LPL FINANCIAL LLC | 02/07/2023 | 41,000 | $11,111 | -4.65% | 6.84% |
| BLACKROCK INC. | 02/13/2023 | 30,209 | $8,186 | -1.80% | 5.04% |
| NORTHERN TRUST CORP | 02/13/2023 | 28,929 | $7,840 | 0.00% | 4.83% |
| WELLS FARGO & COMPANY/MN | 02/13/2023 | 23,159 | $6,276 | -44.98% | 3.86% |
| TWO SIGMA SECURITIES, LLC | 02/14/2023 | 14,149 | $3,834 | -67.95% | 2.36% |
| VIRTU FINANCIAL LLC | 02/15/2023 | 13,123 | $4,000 | 100.00% | 2.19% |
| CALTON & ASSOCIATES, INC. | 01/18/2023 | 13,000 | $3,523 | 0.00% | 2.17% |
| CITADEL ADVISORS LLC | 02/14/2023 | 12,900 | $3,496 | -0.77% | 2.15% |
| GOLDMAN SACHS GROUP INC | 05/14/2024 | 11,033 | $2,990 | 100.00% | 1.84% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/10/2023 | 10,742 | $3,000 | -4.53% | 1.79% |
| MORGAN STANLEY | 02/14/2023 | 8,496 | $2,303 | 0.31% | 1.42% |
| GROUP ONE TRADING, L.P. | 02/09/2023 | 6,301 | $1,708 | -32.40% | 1.05% |
| CITADEL ADVISORS LLC | 02/14/2023 | 500 | $136 | 100.00% | 0.08% |
| PNC FINANCIAL SERVICES GROUP, INC. | 02/10/2023 | 200 | $54 | 100.00% | 0.03% |
| OLIVER LAGORE VANVALIN INVESTMENT GROUP | 03/02/2023 | 135 | $37 | 100.00% | 0.02% |
| HARBOUR INVESTMENTS, INC. | 02/16/2023 | 23 | $6 | 100.00% | 0.00% |
| SIMPLEX TRADING, LLC | 02/02/2023 | 255 | $0 | 100.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/14/2023 | 50 | $0 | -90.00% | 0.00% |
| VITALSTONE FINANCIAL, LLC | 01/30/2023 | 4 | $0 | 100.00% | 0.00% |
| FMR LLC | 02/13/2023 | 0 | $0 | -100.00% | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 01/30/2023 | 0 | $0 | 0.00% | 0.00% |
| AXIOM INVESTMENT MANAGEMENT LLC | 02/14/2023 | 0 | $0 | -100.00% | 0.00% |
| UBS GROUP AG | 02/08/2023 | 0 | $0 | -100.00% | 0.00% |
Arcadia Biosciences, Inc.institutional Ownership - FAQ's
During the previous two years, 3 institutional investors and hedge funds held shares of Arcadia Biosciences, Inc.. The most heavily invested institutionals were:
Axiom Investment Management LLC: 0
LADENBURG THALMANN FINANCIAL SERVICES INC.: 100
Advisor Group, Inc.: 0
394.82% of Arcadia Biosciences, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 100 shares in the last 24 months. This purchase volume represents approximately $494 in transactions.